ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,865
0,28%
Bitcoin
59 761,20
1,08%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Pulse Biosciences Inc (PLSE)

  7. Pulse Biosciences Inc (PLSE) Actualités

PLSE Pulse Biosciences Inc

8,05
0,45 (5,92%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Pulse Biosciences Inc PLSE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,45 5,92% 8,05 22:00:19
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
7,71 7,52 8,42 8,05 7,60
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202414:00BWPulse Biosciences Announces Timing of Rights Offering for Up..
24/4/202422:05BWPulse Biosciences Schedules First Quarter 2024 Financial..
28/3/202421:12BWPulse Biosciences Reports Business Updates and Fourth..
28/3/202421:10BWPulse Biosciences Announces Plans to Initiate a Rights..
14/3/202421:05BWPulse Biosciences Schedules Fourth Quarter & Full Year 2023..
11/3/202414:10EDGAR2Form 8-K - Current report
08/3/202419:17BWPulse Biosciences Announces FDA 510(k) Clearance for its..
14/2/202415:22EDGAR2Form 8-K - Current report
14/2/202414:00BWPulse Biosciences Announces Positive 60-Day Follow-Up..
31/1/202414:00BWPulse Biosciences Announces Preliminary Findings from its..
09/1/202415:20EDGAR2Form 8-K - Current report
02/1/202415:20EDGAR2Form 8-K - Current report
02/1/202414:00BWPulse Biosciences Files 510(k) Submission with U.S. FDA for..
22/12/202315:08EDGAR2Form 8-K - Current report
20/12/202315:06EDGAR2Form 8-K - Current report
20/12/202314:00BWPulse Biosciences Announces First-in-Human Procedures with..
27/11/202323:29EDGAR2Form DEF 14A - Other definitive proxy statements
27/11/202315:08EDGAR2Form 8-K - Current report
21/11/202315:03EDGAR2Form 8-K - Current report
21/11/202314:00BWPulse Biosciences Files 510(k) Submission with U.S. FDA for..
17/11/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202322:05BWPulse Biosciences to Present at the 35th Annual Piper..
13/11/202323:21EDGAR2Form PRE 14A - Other preliminary proxy statements
13/11/202323:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:12EDGAR2Form 8-K - Current report
13/11/202314:00BWPulse Biosciences Reports Business Updates and Third Quarter..
10/11/202322:56BWUPDATE Pulse Biosciences Announces New Time for Third..
03/11/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:05BWPulse Biosciences Schedules Third Quarter 2023 Financial..
24/10/202314:00BWPulse Biosciences Appoints Dr. Niv Ad as Chief Science..
02/10/202314:00BWPulse Biosciences Announces Collaboration with CardioNXT for..
29/9/202314:00BWPulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™)..
27/9/202314:00BWPulse Biosciences’ First Study in a Surgical Application of..
12/9/202315:15EDGAR2Form 8-K - Current report
07/9/202322:05BWPulse Biosciences to Present at Gilmartin Group Emerging..
31/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
24/8/202322:05BWPulse Biosciences Clarifies Details of Recent S-3 Filing
11/8/202322:49EDGAR2Form S-3 - Registration statement under Securities Act of..
10/8/202322:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:14EDGAR2Form 8-K - Current report
10/8/202322:05BWPulse Biosciences Reports Business Updates and Second..
27/7/202322:05BWPulse Biosciences Schedules Second Quarter 2023 Financial..
20/7/202315:25EDGAR2Form 8-K - Current report
15/7/202302:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/7/202302:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202313:00BWPulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™)..
11/5/202322:05BWPulse Biosciences Reports Business Updates and First Quarter..
10/5/202315:29BWPulse Biosciences, Inc. Announces Planned Redemption of..

Dernières Valeurs Consultées

NASDAQ
PLSE
Pulse Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés